Related references
Note: Only part of the references are listed.Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways
ChongZhe Pei et al.
PHYTOTHERAPY RESEARCH (2019)
Gastrodin Protects against Ethanol-Induced Liver Injury and Apoptosis in HepG2 Cells and Animal Models of Alcoholic Liver Disease
Yong Zhang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice
Lijun Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity
Gema Marin-Royo et al.
DISEASE MODELS & MECHANISMS (2018)
Galectin-3 levels relate in children to total body fat, abdominal fat, body fat distribution, and cardiac size
Magnus Dencker et al.
EUROPEAN JOURNAL OF PEDIATRICS (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-gamma and subsequent expression of HGF in colons
Chunge Guan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats
Laila Ahmed Eissa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Obesity and nonalcoholic fatty liver disease: current perspectives
Raiya Sarwar et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2018)
Protective effect of berberine on renal fibrosis caused by diabetic nephropathy
Zhong Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Effect of Weight Gain and Weight Loss on In Vivo Colonocyte Proliferation Rate in People with Obesity
Faidon Magkos et al.
OBESITY (2017)
Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway
Li-Li Qu et al.
PHYTOTHERAPY RESEARCH (2016)
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Pingping Li et al.
CELL (2016)
Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure
Eline L. Vegter et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Galectin-3 inhibition prevents adipose tissue remodelling in obesity
E. Martinez-Martinez et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Functional study of the upregulation of miRNA-27a and miRNA-27b in 3T3-L1 cells in response to berberine
Yue-Yue Wu et al.
MOLECULAR MEDICINE REPORTS (2016)
Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis
Stefano Menini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Relationship of galectin-3 with obesity, IL-6, and CRP in women
J. Pang et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results
Grazyna Sygitowicz et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2015)
Galectin-3 Activates PPARγ and Supports White Adipose Tissue Formation and High-Fat Diet-Induced Obesity
Jung-Hwan Baek et al.
ENDOCRINOLOGY (2015)
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Nonivamide Enhances miRNA let-7d Expression and Decreases Adipogenesis PPARγ Expression in 3T3-L1 Cells
Barbara Rohm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Jiarong Lan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity
Juan Zhang et al.
PLOS ONE (2015)
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
Hong-Mei Yan et al.
PLOS ONE (2015)
Galectin-3: an emerging all-out player in metabolic disorders and their complications
Giuseppe Pugliese et al.
GLYCOBIOLOGY (2015)
Learning from berberine: Treating chronic diseases through multiple targets
Yao Jing et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Free fatty acids and IL-6 induce adipocyte galectin-3 which is increased in white and brown adipose tissues of obese mice
Sabrina Krautbauer et al.
CYTOKINE (2014)
Berberine activates thermogenesis in white and brown adipose tissue
Zhiguo Zhang et al.
NATURE COMMUNICATIONS (2014)
Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
Nada N. Pejnovic et al.
DIABETES (2013)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Adipose Tissue-Specific Modulation of Galectin Expression in Lean and Obese Mice: Evidence for Regulatory Function
Davina H. Rhodes et al.
OBESITY (2013)
Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
Jingbo Pang et al.
PLOS ONE (2013)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
A Novel Function of MicroRNA Let-7d in Regulation of Galectin-3 Expression in Attention Deficit Hyperactivity Disorder Rat Brain
Lihui Wu et al.
BRAIN PATHOLOGY (2010)
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Yueshan Hu et al.
FITOTERAPIA (2010)
Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation
Y. Hu et al.
PHYTOMEDICINE (2009)
The MUC1 and galectin-3 oncoproteins function in a MicroRNA-dependent regulatory loop
Selvi Ramasamy et al.
MOLECULAR CELL (2007)
Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue
Kohji Kiwaki et al.
OBESITY (2007)
Adipocytes as regulators of energy balance and glucose homeostasis
Evan D. Rosen et al.
NATURE (2006)
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Cheng Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor
C Iacobini et al.
FASEB JOURNAL (2004)
Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice
G Pugliese et al.
FASEB JOURNAL (2001)
Share Paper
